Abstract
In this chapter, I chart the historical emergence of key international and national guidelines that govern medical research in general, and clinical drug trials in particular. The principle of informed consent, is central to these guidelines and has come to be seen as ‘the ethical solution’ to prevent the exploitation and abuse of human subjects. I present a critical examination of the central role accorded to this principle and challenge its emancipatory status. I draw upon a number of studies to illustrate the effects of the implementation of informed consent in various social contexts. Finally, I argue the central role accorded to informed consent obfuscates other ethical issues relating to the broader political and institutional setting
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Copyright information
© 2003 Palgrave Macmillan, a division of Macmillan Publishers Limited
About this chapter
Cite this chapter
Corrigan, O. (2003). The Limitations of Current Ethical Regulations. In: Abraham, J., Smith, H.L. (eds) Regulation of the Pharmaceutical Industry. Studies in Regulation. Palgrave Macmillan, London. https://doi.org/10.1057/9780230372597_10
Download citation
DOI: https://doi.org/10.1057/9780230372597_10
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-41892-3
Online ISBN: 978-0-230-37259-7
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)